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invasive  ductal  carcinoma,  lesion  margin  and  inner  pattern
were  better  evaluated  at  early  images  (Fig.  3).LETTER TO THE EDITOR / Breast imaging
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The  article  ‘‘Dual-energy  contrast-enhanced  digital
mammography  in  routine  clinical  practice  in  2013’’  by  Badr
et  al.  [1]1,  describes  the  contrast-enhanced  digital  mam-
mography  (CEDM)  technique,  its  use  in  clinical  practice,
authors  feedback,  as  well  as  its  limitations.  The  examination
protocol  proposed  has  some  conﬂicting  points.
On  breast  magnetic  resonance  imaging  (MRI),  enhance-
ment  kinetics  analysis  is  essential.  It  is  evaluated  in  the
early  phase  and  in  the  intermediate  and  late  post  contrast
phases.  Malignant  lesions  have  strong  signal  increase  (more
than  100%),  followed  by  a  washout  pattern  while  benign
lesions  have  mild  increase  (70—80%)  and  persistent  pattern
[2].
There  is  a  doubt  if  iodine  behaves  similar  to  gadolinium
contrast  in  breast  exams.  Froeling  et  al.  [3]  found  statisti-
cally  signiﬁcant  correlation  between  contrast  agent  kinetics
curves  for  spectral  contrast-enhanced  breast  tomosynthesis
using  iodine  and  MRI  with  gadolinium.  Using  CEDM  with  tem-
poral  subtraction  technique,  Jong  et  al.  [4]  found  washout
pattern  in  30.0%  all  malignant  lesions  and  Dromain  et  al.  [5]
in  19.0%.  All  enhancing  benign  lesions  at  Jong’s  study  had
persistent  curve.
Dual-energy  contrast-enhanced  digital  mammography
does  not  provide  the  possibility  of  enhancement  kinetic
analyses  but  sometimes  the  enhancement  pattern  can  be
assessed  visually.
As described  by  Badr  et  al.  [1],  motion  blur  is  an  artifact
occasionally  observed.  In  our  experience,  it  is  seen  almost
only  in  mediolateral  oblique  view.  It  can  also  be  observed
in  published  papers,  including  Badr’s  [1].  The  main  issue  of
motion  blur  is  that  it  can  mask  lesions.Badr  et  al.  [1]  describe  the  following  examination
protocol:  ﬁrst  image  is  performed  two  minutes  after
contrast-media  injection  with  an  interval  of  one  minute
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http://dx.doi.org/10.1016/j.diii.2014.01.019etween  images.  Mediolateral  oblique  (MLO)  and  crani-
audal  (CC)  views  on  the  non-pathologic  breast  are  ﬁrst
erformed  followed  by  CC  and  MLO  views  on  the  pathologic
reast.  Additional  images  can  be  performed  after  standard
iews.
Based  in  what  we  learn  from  breast  MRI,  since  2012  we
erform  a  different  examination  protocol:
90—120  seconds  (2  minutes)—CC  pathologic  breast;
150—180  seconds  (3  minutes)—CC  non-pathologic  breast;
210—240  seconds  (4  minutes)—MLO  pathologic  breast;
270—300  seconds  (5  minutes)—MLO  non-pathologic  breast;
additional  images  (mediolateral  and/or  spot  compres-
sion).
Performing  CC  view  at  2  minutes,  early  enhancement
hase  can  be  assessed,  as  in  MRI,  and  MLO  motion  blur
rtifact  is  avoided.  It  is  also  possible  to  visually  evalu-
te  enhancement  pattern  without  the  risk  of  missing  rapid
ashout  lesions.  Other  beneﬁts  include:  better  evaluation
f  lesion  contours  and  internal  enhancement.
We  have  cases  of  ﬁbroadenoma  with  no  enhancement
efore  4  minutes  (Fig.  1) and  a multifocal  invasive  lobular
arcinoma  with  washout  pattern  (Fig.  2).  In  some  cases  ofigure 1. CC low-energy view and recombined images. Oval mass
nhancement in upper outer quadrant is seen at late image. Ultra-
ound guided core-biopsy revealed ﬁbroadenoma.
. Published by Elsevier Masson SAS. All rights reserved.
352  
Figure 2. CEDM recombined images show two round mass
enhancement with washout pattern and a pathologic lymph node.
Surgical biopsy showed lobular carcinoma in both nodules.
Figure 3. CEDM recombined CC views. Irregular mass enhance-
ment is seen in outer quadrant. Notice how contour and inner
enhancement patterns are better evaluated at early image. Surgical
biopsy showed invasive ductal carcinoma.
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